female androgenetic alopecia
Conditions
Interventions
Patients with female androgenetic alopecia were randomized to receive 5% azelaic acid. Patients apply 1 cc of 5% azelaic acid on the scalp twice a day for 24 weeks.,Patients with female androgenetic a
Experimental Drug,Experimental Drug
topical 5% azelaic acid ,topical 2% minoxidil solution
Sponsors
Institutional review and signing
Institutional review and signing,
Faculty of Medicine Siriraj Hospital,
Mahidol University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: - Female patients, older than 18 years of age, who were diagnosed with androgenetic alopecia. - Patients have never been treated for at least 6 months prior to the study. - Patients agree to participate in the research project and can complete the treatment throughout the period.
Exclusion criteria
Exclusion criteria: - People with congestive heart disease, such as anemia, diabetes, chronic alcoholism, previous gastrointestinal surgery, short bowel syndrome, Crohn's disease, digestive disorder, hypo / hyperthyroidism, autoimmune disease - Patients with other skin lesions in the treatment area, such as psoriasis, fungal infection on the scalp - Patients with impaired mental status, including trichotillomania
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparative efficacy of 5% azelaic acid and 2% minoxidil solution in female androgenetic alopecia 6 months To evaluate the difference of hair density, hair shaft diameter | — |
Secondary
| Measure | Time frame |
|---|---|
| To study the safety of 5% azelaic acid and 2% minoxidil solution 6 months history and physical examination every visits after applying the study's drug | — |
Countries
thailand
Contacts
Public ContactKanchalit Thanomkitti
Department of dermatology, Siriraj Hospital, Mahidol university
Outcome results
None listed